Focus on Outpatient Quality Improvement
Our initiatives - Target: BP™, Target: Type 2 Diabetes and Check. Change. Control. Cholesterol™ - work together to reduce cardiovascular deaths, heart attacks, and strokes among the 100 million+ Americans living with hypertension, high cholesterol and/or type 2 diabetes.
Do you want to celebrate your team’s work to manage blood pressure, high cholesterol and Type 2 diabetes? Data submission for American Heart Association outpatient recognition programs is open Jan. 1 through May 19, 2023. Questions or need support? Contact us.(link opens in new window)(link opens in new window)(link opens in new window)
Congratulations 2022 Gold
Level Achievers!
Our Gold Level Recognition Winners were recognized for their ongoing commitment to provide better care for hypertension, high cholesterol, or type 2 diabetes patients in the November issue of Modern Healthcare.
Subscribers can view the digital issue.(link opens in new window)
Be Recognized for your Efforts in Outpatient Care!
These organizations are being recognized for their ongoing commitment to provide better care for patients diagnosed with hypertension, high cholesterol, or type 2 diabetes.
Check. Change. Control. Cholesterol™ (PDF)Target: BP™ (PDF)
Target: Type 2 Diabetessm (PDF)
Join us!
Register now to enroll in the initiative and receive timely information about data submission and recognition opportunities. Registration is available year-round.
Outpatient Registry Innovators
The American Heart Association recognizes these organizations for its efforts to pilot test a new Outpatient Quality Improvement Registry to improve chronic disease management and reduce the prevalence of cardiovascular disease.
Webinars and Audiocasts
Stay up-to-date with informative resources and timely updates to help improve your outpatient quality improvement efforts.
Data Submission
Input your data, track your results and help drive evidence-based science forward.
Vascular Medicine Consult Registry
Working to improve quality of life and patient care in vascular medicine, the AHA and SVS VQI® announce a new registry targeting the medical management of vascular disease.
